Physicians weigh in on long-term use of IBD treatments

06/17/2013 | Gastroenterology & Endoscopy News

Patients with inflammatory bowel disease may want to discontinue treatment once they achieve remission but Dr. David Rubin of the Inflammatory Bowel Disease Center at the University of Chicago says it is important to remember IBD is a chronic disease and stopping therapy can lead to recurrence. Physicians say there are limited data on even de-escalating treatments. There may be some cases in which scaling back is appropriate, but the science is still emerging, Rubin and others said.

View Full Article in:

Gastroenterology & Endoscopy News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX